Estimates Revisions PharmaEssentia Corporation LUXEMBOURG S.E.
Stocks
261280558
US7169721047
Biotechnology & Medical Research
|
End-of-day quote
LUXEMBOURG S.E.
14/08/2026
|
5-day change | 1st Jan Change | ||
| 47.00 USD | +4.44% |
|
+22.40% | +247.80% |
| 13/08 | PharmaEssentia Clarifies Report Projecting 2026 Revenue | MT |
| 12/08 | PharmaEssentia Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 6446 Stock
- 261280558 Stock
- Consensus PharmaEssentia Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
